Related Experiment Video
Updated: Jan 7, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Shared Decision-Making in Curative Uro-Oncology: A Systematic Review
Line Bentsen1, Trine Lund-Jacobsen2, Christina Bøgh Jakobsen1
1Department of Oncology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Objectives:
To synthesize current evidence on shared decision-making (SDM) processes that guide the choice of curative-intent treatment among patients with prostate or bladder cancer.
Methods:
Following PRISMA 2020 guidelines, we searched seven databases from inception to November 2024 for randomised, observational, and qualitative studies evaluating SDM in treatment selection for localized prostate or bladder cancer. Two reviewers independently screened, extracted data, and appraised quality using the Mixed-Methods Appraisal Tool.
Results:
Ten studies (n = 11,506) met inclusion criteria: eight on prostate cancer, one on muscle-invasive bladder cancer, and one mixed cohort. Designs included three randomized controlled trials, five quantitative observational, and two qualitative studies. Structured interventions, decision aids, and joint consultations consistently reduced decisional conflict, improved satisfaction, and sometimes shifted choices toward preference-sensitive options. Nonetheless, reported "involvement" often masked gaps, including limited discussion of long-term side-effects and insufficient clarification of patient preference. Seven studies were rated minimal risk of bias, though many had small samples, restricted blinding, or lacked real-time quality-of-life data. Evidence for bladder cancer was limited to one exploratory study.
Conclusions:
Structured SDM interventions and multidisciplinary counselling generally improve decision quality in curative-intended prostate or bladder cancer treatment. Yet, critical elements remain underutilized despite being highly valued by patients. Future work should extend to bladder cancer, incorporate patient-reported outcomes, and test scalable multidisciplinary SDM models to ensure informed, value-concordant care.
Implications For Nursing Practice:
Oncology nurses are central to SDM by clarifying patient preferences, addressing side effects, and supporting decision aid use. Their sustained patient relationships foster trust and communication, while nurse-led roles-such as preference elicitation clinics, toxicity prehabilitation counselling, and survivorship navigation-offer structured opportunities to embed SDM. Scripts, checklists, and well-timed consultations can make these approaches consistent and sustainable in everyday practice.
More Related Videos
05:19A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
06:39Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
Published on: November 22, 2019
Related Concept Videos
Cancer Survival Analysis
Urinary Tract Calculi VI: Surgical Management
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Urinary Tract Calculi III: Medical Management
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...